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INTRODUCTION
Advances  in  perinatal  care  and  the  establishment  of  neonatal  nurseries  have 
improved the survival chances of many neonates that would otherwise have succumbed. 
As more of these babies survive; the chances of childhood developmental delay, speech 
problems, behavioural problems, attention deficit hyperkinetic behaviour and scholastic 
backwardness increase. Very often their problems are identified quite late, may be at 
school  age  when  only  some  rehabilitation  measures  can  be  taken,  which  does  not 
necessarily bring out the best in the child. Such issues are of paramount importance to 
the average Indian parents, obviously because of ready acceptance of small family norm, 
resulting in a new thrust on quality of the child. Hence if we have special care/intensive 
care services in our hospital, it should be mandatory that we offer neonatal follow up 
and early  stimulation services.  It  is  true that  there are many sophisticated,  scientific 
methods for the assessment of development in children, but what we need is simple 
screening procedures which can be used in the community by field workers and can be 
propagated even among illiterate mothers.   
 Notwithstanding the huge advances in our understanding of the mechanisms that 
contribute  to  the  injuries  of  the  developing  brain  and  many  efforts  at  prevention, 
perinatal  brain  injury  continues  to  be  a  major  cause  of  neonatal  mortality  and  is 
associated with long term neurodevelopmental  sequelae1.It  ranks as the second most 
important cause of neonatal death after infections, accounting for around 30% mortality 
worldwide1. Although many organ systems can be affected by hypoxia-ischemia, it is 
the nervous system that bears the brunt of perinatal asphyxia in the long run. The risk of 
developing  cerebral  palsy  and  other  neurodevelopmental  sequelae  is  more  in  the 
asphyxiated newborn than in the general population. So if these infants with Hypoxic 
Ischemic Encephalopathy are followed up for sufficient period of time and any deviation 
from normal neurodevelopment is detected early, appropriate interventional measures 
can be initiated early.
          Our hospital is a tertiary referral centre for neonatal care for Corporation hospitals 
and Private hospitals within a radius of 100 kms. Roughly about 500 cases of birth 
asphyxia are admitted in this hospital each year.
Table 1:Hospital statistics of ICH, Chennai
Hospital statistics 2004 2005 2006
Total no of admissions in the hospital 38608 36948 35885
Total no of admissions in newborn unit 3596 3807 3625
No of deaths in newborn unit 677 720 724
No of admissions with HIE 602 557 579
No of deaths among HIE 293 229 200
         High risk newborn follow up clinic is conducted daily in our hospital, where these 
babies  who  had  HIE  are  followed  up,  neurodevelopmental  assessment  done,  and 
appropriate rehabilitation initiated.
          
HYPOXIC ISCHEMIC ENCEPHALOPATHY
 In spite of major advances in monitoring technology and knowledge of fetal and 
neonatal  pathologies,  perinatal  asphyxia  or,  more  appropriately,  hypoxic-ischemic 
encephalopathy (HIE), remains a serious condition, causing significant  mortality and 
long-term morbidity. HIE is characterized by clinical and laboratory evidence of acute 
or subacute brain injury due to asphyxia (i.e., hypoxia, acidosis).The exact time of brain 
injury often remains uncertain.
Definition
                   There is no unanimity or consensus regarding the definition of birth 
asphyxia  and  various  workers  have  used  different  definitions  making  it  difficult  to 
ascertain  the  incidence  of  asphyxia.  The  National  Neonatology  Forum of  India  has 
defined asphyxia as “gasping or ineffective breathing or lack of breathing at one minute 
of life”2. 
The essential criteria for diagnosing perinatal asphyxia as outlined by American 
Academy of Paediatrics (AAP)2 are 
• Prolonged metabolic or mixed acidemia (pH <7.0 on cord arterial blood sample) 
• Persistence of an Apgar score of <3 for 5 min or longer 
• Clinical neurologic manifestation as seizures, hypotonia, coma              or HIE in 
the immediate neonatal period 
• Evidence  of  multi-organ  system  dysfunction  in  the  immediate 
neonatal period 
Amiel Tison has defined HIE as a condition with signs and symptoms of neurologic 
dysfunction and stereotypical evolution in the clinical course.
Pathophysiology
Brain hypoxia and ischemia due to systemic hypoxemia, reduced cerebral blood 
flow (CBF), or both are the primary physiological processes that trigger HIE. The initial 
compensatory adjustment to an asphyxial event is an increase in the CBF due to hypoxia 
and hypercapnia. This is accompanied by a redistribution of cardiac output such that the 
brain receives an increased proportion of the cardiac output. A borderline increase in the 
systemic  blood  pressure  (BP)  further  enhances  the  compensatory  response.  The  BP 
increase is due to increased release of epinephrine; these are classic early cardiovascular 
compensatory responses to  asphyxia.  In  the fetus and newborn suffering from acute 
asphyxia, after the early compensatory adjustments fail, the CBF can become pressure-
passive, at which time brain perfusion is dependent on systemic BP. As BP falls, CBF 
falls  below critical  levels,  and  the  brain  continues  to  suffer  from diminished  blood 
supply and a  lack of  sufficient  oxygen to meet  its  needs.  This  leads to intracellular 
energy failure. During the early phases of brain injury, brain temperature drops, and 
local release of the neurotransmitters, such as gamma aminobutyric acid transaminase 
(GABA),  increase.  These  changes  reduce  cerebral  oxygen  demand,  transiently 
minimizing the impact of asphyxia. 
At  the  cellular  level,  neuronal  injury  in  HIE  is  an  evolving  process.  The 
magnitude of the final neuronal damage depends on both the severity of the initial insult 
and the damage due to reperfusion injury and apoptosis. Following the initial phase of 
energy  failure  from the  asphyxial  injury,  cerebral  metabolism may  recover,  only  to 
deteriorate in the secondary phase, or reperfusion. This new phase of neuronal damage, 
starting at about 6-24 hours after the initial injury, is characterized by cerebral edema 
and apoptosis. This phase has been called the "delayed phase of neuronal injury." The 
duration of the delayed phase is not known precisely in the human fetus and newborn 
but appears to increase over the first 24-48 hours and then start to resolve thereafter. 
At  the  biochemical  level,  a  large  cascade  of  events  follow HIE  injury.  Both 
hypoxia and ischemia increase the release of excitatory amino acids (EAAs), such as 
glutamate and aspartate, in the cerebral cortex and basal ganglia. EAAs cause neuronal 
death through the activation of receptor subtypes such as kainate, N-methyl-D-aspartate 
(NMDA), and amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA). Activation 
of receptors, with associated opening of ion channels (e.g., NMDA), lead to increased 
intracellular and subcellular calcium concentration and cell death. A second important 
mechanism for the destruction of ion pumps is the lipid peroxidation of cell membranes, 
in which enzyme systems, such as the Na+/K+-ATPase, reside; this can cause cerebral 
edema  and  neuronal  death.  The  EAAs  may  also  disrupt  the  factors  that  control 
apoptosis, increasing the pace and extent of programmed cell death. 
Histologic Findings
The neuropathology of neonatal HIE varies considerably. Brain maturity at the time 
of the insult is an important factor in the evolution of neuropathology. In the preterm 
infant,  the  damage  is  at  the  germinal  matrix  area,  leading  to  hemorrhage  in  the 
subependymal region, the germinal matrix, or the intraventricular region. In the full-term 
infant, the pathology is mainly in the cerebral cortex and in the basal ganglia. Selective 
neuronal necrosis is the most common neuropathology. Major sites of necrosis are the 
cerebral cortex, diencephalon, basal ganglia, brain stem, and cerebellum.. 
• Selective neuronal necrosis: This injury occurs at specific sites to specific cell 
types  (neurons  >  glia).The  damage selectively  involves  hippocampus,  lateral 
geniculate  body,  thalamus,  caudate  nucleus,  putamen,  globus pallidus,  motor 
nuclei of the fifth and seventh cranial nerves and dorsal vagal nuclei.
• Parasagittal  cerebral necrosis: This lesion is bilateral, usually symmetrical, and 
occurs in the cerebral cortex and the subcortical white matter, especially in the 
parietooccipital  regions.  These regions represent the border  zones of perfusion 
from major cerebral arteries. 
• Status  marmoratus:  In  this  lesion,  the  basal  ganglia,  especially  the  caudate 
nucleus,  putamen,  and  thalamus,  demonstrate  neuronal  loss,  gliosis,  and 
hypermyelination, leading to a marble white discoloration of these regions. This is 
the least common type of neuropathology, and its full evolution may take months 
to years. 
• Focal and multifocal ischemic brain necrosis: These lesions are relatively large, 
localized areas of necrosis of cerebral parenchyma, cortex, and subcortical white 
matter. The most frequently affected region is the zone perfused by the middle 
cerebral artery.
• Periventricular  leukomalacia:  This  lesion is  characterized by necrosis  of  white 
matter, which is seen grossly as white spots adjacent to the external angle of the 
lateral ventricles. These sites are the border zones between penetrating branches 
of major cerebral arteries. These lesions are more common in preterm than in term 
infants.
Clinical Features
The symptoms of moderate-to-severe HIE are almost always manifested at birth or 
within a few hours after birth. Clinical manifestations and course vary depending on 
HIE severity. 
• Mild HIE
o Muscle tone may be increased slightly and deep tendon reflexes may be 
brisk during the first few days.
o Transient behavioural abnormalities,  such as poor feeding,  irritability,  or 
excessive crying or sleepiness, may be observed.
o By 3-4 days of life, the CNS examination findings become normal.
• Moderately severe HIE
o The  infant  is  lethargic,  with  significant  hypotonia  and  diminished  deep 
tendon reflexes. 
o The grasping, Moro, and sucking reflexes may be sluggish or absent. 
o The infant may experience occasional periods of apnea.
o Seizures may occur within the first 24 hours of life.
o Full recovery within 1-2 weeks is possible and is associated with a better 
long-term outcome.
o An initial period of well-being or mild HIE may be followed by sudden 
deterioration, suggesting ongoing brain cell dysfunction, injury, and death; 
during this period, seizure intensity might increase.
• Severe HIE
o Stupor  or  coma is  typical.  The  infant  may not  respond to  any  physical 
stimulus. 
o Breathing  may  be  irregular,  and  the  infant  often  requires  ventilatory 
support. 
o Generalized hypotonia and depressed deep tendon reflexes are common. 
o Neonatal reflexes (e.g., sucking, swallowing, grasping, Moro) are absent. 
o Disturbances of  ocular  motion,  such as  a skewed deviation of  the eyes, 
nystagmus, bobbing, and loss of "doll's eye" (i.e., conjugate) movements 
may be revealed by cranial nerve examination.
o Pupils may be dilated, fixed, or poorly reactive to light.
o Seizures occur early and often and may be initially resistant to conventional 
treatments. The seizures are usually generalized, and their frequency may 
increase during the 24-48 hours after onset, correlating with the phase of 
reperfusion injury. As the injury progresses, seizures subside and the EEG 
becomes  isoelectric  or  shows a  burst  suppression  pattern.  At  that  time, 
wakefulness  may  deteriorate  further,  and  the  fontanelle  may  bulge, 
suggesting increasing cerebral edema.
o Irregularities  of  heart  rate  and  BP  are  common  during  the  period  of 
reperfusion injury, as is death from cardiorespiratory failure.
• Involvement of multiple organs besides the brain is a hallmark of HIE. Reduced 
myocardial  contractility,  severe  hypotension,  severe  pulmonary  hypertension 
requiring assisted ventilation, renal failure may occur in the first few days of life. 
The  staging system proposed by Sarnat  and Sarnat  in  1976 is  often useful  in 
classifying  the  degree  of  encephalopathy.  Stages  I,  II,  and  III  correlate  with  the 
descriptions of mild, moderate, and severe encephalopathy described above. 
Lab Studies
            No specific test can always confirm or exclude a diagnosis of HIE, since a 
diagnosis  of  HIE  is  made  based  on  the  history  and  physical  and  neurological 
examinations.  Routine imaging studies may or may not consistently reveal abnormal 
findings. Therefore, a normal cranial imaging study does not rule out HIE.
Cranial Ultrasonography
          Sonography may be useful as the initial neuroimaging study in the examination of 
term infants with suspected brain injury. However, as many as 50% of neurosonograms 
in neonates with HIE are normal.  Ultrasonography is most useful for the detection of 
PVL.  Selective  neuronal  injury  and  parasagittal  or  watershed  lesions  are  frequently 
missed on sonography. Ultrasonography has poor specificity in differentiating increased 
echogenicity  due to ischemic or  hemorrhagic  lesions.  Focal  and multifocal  ischemic 
lesions, especially small cortical infarcts, may be missed on sonography but detected on 
CT or MRI.  Early,  large ischemic infarcts  (e.g.,  large infarct  of the middle cerebral 
artery) may be observed on ultrasonography before it is apparent on CT.
Computed tomography
CT depicts focal,  multifocal,  and generalized ischemic lesions. In the first  few 
days  after  a  severe  hypoxic-ischemic  insult,  bilateral  hypoattenuations  are  seen  and 
probably reflect both neuronal injury and edema. Diffuse cortical injury is not initially 
detected on CT. After days to weeks, diffuse hypoattenuation may appear, with loss of 
the gray  matter–white matter  differentiation.  Diffuse cerebral  atrophy with ex vacuo 
ventricular dilatation due to severe hypoxemic insult may take several weeks to develop. 
A CT scan demonstrating generalized, diffuse hypoattenuation after a hypoxic-ischemic 
event  is  predictive  of  both  neonatal  death  and  long-term severe  disability,  whereas 
normal CT findings are predictive of mild disability or a normal outcome. Interpretation 
of normal results should be done with caution because hypoattenuation may take a few 
weeks to develop. 
Magnetic Resonance Imaging
 MRI  is  the  imaging  modality  of  choice  in  the  assessment  of  HIE,  and  it  is 
sensitive  in  detecting  focal  and  multifocal  ischemic  lesions.  Changes  on  DWI  are 
correlated with clinical outcomes and have been reported within 6-8 hours of life in 
neonates who had presumed HIE. 
In the premature infant,  an acute  PVL lesion can be demonstrated on MRI.  This 
pattern has been correlated with spastic diplegia in formerly premature infants with a 
history  of  PVL,  but  it  is  also  frequently  observed  in  term  infants  after 
HIE.Abnormalities  of  the  basal  ganglia,  thalamus,  and  internal  capsule  have  been 
correlated  with  motor  dysfunction  on  the  first  3  years  of  life.  The  watershed  or 
parasagittal pattern of insult is associated with late cognitive impairment.
Magnetic  resonance  spectroscopy  may  reveal  indirect  evidence of  neuronal 
damage by showing a decreased ratio of  N-acetylaspartate (NAA) to choline and by 
showing elevated lactate peaks. These findings are somewhat correlated with subsequent 
neurologic  deficits.  High  lactate-to-choline  ratios  with  basal  ganglial  and  thalamic 
abnormalities appear to be correlated with poor neurologic function after the neonatal 
period. 
Table 2: Summary of MRI and MRS Findings in HIE
Time Finding
24 h Increased lactate peak
24-72 h
Increased NAA-to-choline ratio and DWI 
signal intensity
>72 h Increased T2-weighted signal intensity
1-3 wk
Generalized atrophy (ex vacuo 
hydrocephalus), cystic changes 
(polycystic encephalomata)
Electroencephalograph
 EEG allows for the diagnosis of neonatal seizures and helps in determining the 
prognosis for infants with HIE. EEG studies of neonates with HIE showed that low-
voltage (5- to 15-mV) activity, electrocerebral inactivity (voltage, <5 mV), and burst-
suppression patterns are predictive of a poor outcome on follow-up neurodevelopmental 
examination. One pattern that portends a poor prognosis is the burst-suppression pattern. 
Mortality/Morbidity
In severe HIE, the mortality rate has been reported to be 50-75%. Most deaths 
(55%) occur in the first month, due to multiple organ failure or termination of care. 
The incidence of long-term complications depends on the severity of HIE. Up to 
80% of infants who survive severe HIE develop serious complications, 10-20% develop 
moderately serious disabilities. Among the infants who survive moderately severe HIE, 
30-50%  may  suffer  from serious  long-term  complications,  and  10-20% with  minor 
neurological  morbidities.  Infants  with  mild  HIE  tend  to  be  free  from serious  CNS 
complications. Even in the absence of obvious neurologic deficits in the newborn period, 
long-term functional impairments may be present.
DEVELOPMENTAL ASSESSMENT
             Developmental screening is a brief testing procedure designed to identify 
children  who  should  receive more  intensive  diagnosis  or  assessment3.  The  goal  of 
screening is to identify, as early as possible, developmental disabilities in children at 
high risk so that a treatment or remediation can be initiated at an early age when it is 
most effective. Early screening does not merely mean the administration of a single test 
at one point of time; rather it is a set of processes and procedures used over a period of 
time.  There  is  a  need  to  distinguish  developmental  screening  from  developmental 
assessment and developmental surveillance. Developmental assessment refers to a more 
detailed investigation of developmental delay and is diagnostic in scope. On the other 
hand, developmental surveillance is a continuous, flexible and comprehensive process 
which includes all activities related to the detection of developmental problems and the 
promotion  of  development  during  primary  child  health  care  visits.  Developmental 
surveillance includes identification of parental concerns, child observations, screening, 
immunization and anticipatory guidance4.
Developmental Screening Tests
 Several developmental screening tests are available for use in infants and children.It is 
recommended that screening test should be simple, brief, convenient to use, cover all 
areas of  development,  have adequate  construct  validity,  be applicable to a wide age 
range,  and  have  referral  criteria  that  are  both  specific  and  sensitive5.  Good 
developmental screening tests have sensitivities and specificities of 70% to 80% largely 
because of  the  nature  and  complexity  of  measuring  the  continuous  process of  child 
development6.
          One of the earliest assessment that has been used right in the NICU itself is the 
Brazelton Neonatal Behavioural Assessment Scale7. As this is time consuming this has 
not become very popular.By far the most commonly used screening test is the Denver 
Development  Screening Test  (DDST)-  first  described by Frankenburg and Dodds in 
19673,8. The DDST is used to screen children from two weeks through 6 years of age in 
four  developmental  domains;  gross  motor,  fine  motor  adaptive,  personal  social  and 
language skills. The test consists of 105 items but only those items are administered 
which are appropriate to the child's age. Each item is scored pass or fail. Scores are 
interpreted  as  "abnormal",  "questionable",  or  "normal"  in  each  sector.  The  main 
usefulness of the test  is  that  it  is  easy to administer  and score and does not require 
extensive training or experience in testing. Concerns about the inadequate psychometric 
properties of the DDST prompted a major revision of the test and led to the development 
of Denver II. The major differences between the DDST and Denver II are an increase in 
the language items, inclusion of articulation items, a new age scale, a new category of 
identifying milder delays, and a behavior rating scale. However, this test too has been 
criticized for  its  limited  specificity  and has  not  been extensively  used in  the Indian 
setting. The DDST is most useful in identifying children with moderate to severe motor 
or cognitive deficit. However its usefulness is limited in detecting more subtle delays9.
Trivandrum  Developmental  Screening  Chart10 is  a  simple  developmental  test 
designed and validated for children below 2 years of age. There are 17 test items in the 
chart  chosen  from  the  norms  given  in  the  Bayley  Scales  of  Infant  Development 
(BSID).It does not require any special kit and takes only 5-7 minutes.
Vojta’s neurokinesiological examination is based on 7 postural reactions for early 
diagnosis of abnormal motor function. These reactions include traction reaction, Landau 
reaction, axillar hanging reaction, lateral tilt reaction, Collis horizontalis reaction, Peiper 
Isbert reaction and Collis verticalis reaction11.
Amiel Tison has incorporated a relatively simple method of detecting abnormal 
neurodevelopmental status using various angles. This is a pure neuromotor test and does 
not take into consideration the mental development of the child12.
Baroda Developmental Screening Test (BDST) based on the Baroda norms on 
BSID was  proposed  by  Dr.Phatak13.  This  is  standardized  for  Indian  children  and  is 
widely used. This contains 54 items and tests both motor (22 items) and mental (32 
items) development in the age group of 0-3 years. The items are arranged sequentially 
according to the 97% pass age-placements. They are grouped age-wise: one monthly for 
the first 12 months, three monthly for the next 6 months and six monthly for the next 12 
months. A sensitivity and specificity of 65%-95% has been reported.
 Munich Functional Diagnostic Scale was designed by Thedor Hellbrugge and his 
colleagues at the German Academy for    Developmental Rehabilitation. It is based on 
the state of development in different functional areas. Unlike most other tests, this scale 
does  not  calculate  a  global  developmental  age  or  a  developmental  quotient.  The 
individual  results  of  the seven subtests  are  used  in  planning the therapeutic  starting 
points. The early intervention strategies can be directed to the specific functional area at 
which the child is deficient.
Early interventional therapy 
Early  stimulation  is  now well  established  strategy  for  preventing  or  reducing 
disability  resulting from early  CNS damage.  When there  is  neuronal  damage during 
prenatal period and infancy, pruning of the spared synapses and relocation of the activity 
of  the  damaged  neurons  is  possible  if  the  spared  synapses  could  be  saved  by 
stimulation14.  Early  intervention  improves  the  neurodevelopmental  outcome  by 
preventing active inhibition of the central nervous system pathways due to inappropriate 
input, and supporting the use of modulating pathways during a highly sensitive period of 
brain development. Developmentally supportive care may be associated with improved 
cortical  and  specifically  frontal  lobe  development  from early  on.  This  explains  the 
positive lasting effects into school age.
REVIEW OF LITERATURE
Assessment of the developmental status of the child is gaining more importance, 
especially  of  the at  risk  neonates,  in  this  era  of  advanced health  infrastructure.  The 
studies on the neurodevelopmental assessment of infants were started by Arnold Gessel15 
who  started  his  studies  on  the  development  of  infants  as  early  as  1920.  Dr.  Juli 
Richmond described the last two decades as ‘Era of child development and prevention in 
pediatrics’. Research and research techniques in child development have burgeoned.
In a study by Jaimin M Patel  et  al16 at  a  tertiary care centre in Jamnagar,  36 
neonates with HIE II and HIE III were followed up for a period of 1 year. Neurological 
examination was done on day 3, day 7 and every 3 monthly for the 1st year by Amiel 
Tison method. Trivandrum Developmental Screening Chart was carried out separately. 
34% of HIE II  children  and 44% of  HIE III  children developed moderate  to  major 
deficit. Neurological examination at day 7 had a statistically significant association with 
abnormal  neurological  examination at  1  year.  TDSC had a  sensitivity  of  92.31% in 
screening moderate and major deficit but only 68% in detecting minor deficit.
A prospective  study  was  conducted  by  Samatha  and  Maiya11 at  the  Neonatal 
Intensive Care Unit of M.S. Ramaiah Medical Teaching Hospital, Bangalore, between 
October 1994 and January 1997. There were 167 babies with HIE who were discharged 
alive  and were  enrolled  for  the  follow-up.  However,  only  91  infants  completed  the 
follow-up till 1 year of age and only these infants were used for the final analysis. There 
were 28 in HIE Stage I, 37 in HIE Stage II and 26 in HIE Stage III. At one year normal 
development was seen in 94.6% of HIE Stage I, 62.2% of HIE Stage II and 23% of HIE 
Stage  III.  The  proportion  of  infants  with  significant  abnormal  Vojta  reactions  (>3) 
increased significantly with increasing HIE staging. The sensitivity, specificity, positive 
and  negative  predictive  values  were  100% when  >3  abnormal  Vojta  reactions  of  3 
months were used to detect one year neurodevelopmental outcome.
Healingly O et al17 studied fifty seven full-term newborn infants with a diagnosis 
of  HIE consecutively  admitted  to  the  neonatal  intensive  care  unit  in  a  tertiary  care 
centre. Occurrences of seizures during the first 24 hours, cranial ultrasonography (US) 
findings  within  the  first  5  days  of  life,  and  Denver  developmental  screening test  II 
(DDST II) at 6 months of age, were analyzed in relation to mortality and neurological 
status at 2 years of age. Of the 57 infants, 10 were lost to follow-up. Twenty of the 
remaining 47 infants had a severe adverse outcome. Among the predictors of severe 
adverse outcome, occurrence of seizures was found to have a poor predictive accuracy. 
Cranial  US  had  100%  sensitivity,  however  with  a  rather  low  specificity  (55%). 
However,  DDST  II  at  6  months  of  age,  yielded  a  very  high  predictive  accuracy 
(sensitivity=100%, specificity=95%). It was concluded that DDST II at 6 months of age 
could be used in predicting severe neurological outcome in infants with HIE.
   Deorari  AK et  al18 studied  36  neonates  with  severe  birth  asphyxia,  32  with 
moderate birth asphyxia and 35 controls matched for weight and gestation. They were 
followed  up  prospectively  for  neurodevelopmental  outcome.  6  neonates  with  severe 
birth  asphyxia  had  abnormal  neurological  signs  such  as  delayed  sucking,  hypo  or 
hypertonia,  apneic  spell  or  seizures.  Of  these  only  2  had  delayed  developmental 
milestones. The study highlights the fact that a majority of survivors of birth asphyxia 
enjoy  good  quality  of  life  thus  emphasising  the  need  for  vigorous  management  of 
asphyxiated babies at birth.
       In a study by Robertson C et al19, a total of 167 term neonates with a diagnosis of 
hypoxic-ischemic  encephalopathy  had  detailed  neurodevelopmental  follow-up  at  3.5 
years of age. All 66 children with mild HIE were free from handicap; all seven with 
severe HIE were severely handicapped; and of the 94 with moderate HIE at birth, 21.3 
per cent were handicapped. Mean IQ was significantly related to the category of HIE. 
Within the moderate HIE category; the neurological examination at discharge from the 
Neonatal Intensive Care Unit was more useful than the presence of neonatal convulsions 
in  identifying  children  with  subsequent  developmental  delay.  Although  neonatal 
convulsions were associated with an increased number of handicapped children, they did 
not  significantly  affect  most  other  developmental  outcome measures.  In term infants 
with  documented  HIE  at  birth,  major  neurodevelopmental  dysfunction  at  3.5  years 
depended more on prospectively established category of HIE than on other perinatal or 
social factors.
           Finer NN20 and his colleagues followed up forty nine term infants shown to have 
HIE. All infants survived the neonatal period, and all but two infants (seen at 12 months) 
were followed up to at least 27 months of age. Factors that significantly correlated with 
outcome included the Sarnat  encephalopathy stage  and the occurrence of  intractable 
seizures. There was no association between the one- or five-minute Apgar score, the 
need  for  early  ventilation,  the  EEG,  the  occurrence  of  seizures,  and  the  subsequent 
outcome.
            Misra et al21 studied 64 term infants with APGAR <6 at 5 minutes and 90 
controls. 40 cases and 48 controls turned out for complete follow up. Mortality and poor 
neurodevelopmental outcome correlated inversely with the Apgar scores at 5 and 10 
minutes. The outcome of babies with low 5 minute Apgar was significantly better than 
those with same scores at 10 minutes. Symptomatic neonates with same Apgar showed 
significantly poorer outcome.
In  a  prospective  study, Mejaski-Bosnjak  et  al22 correlated  USG  and 
neurodevelopmental handicap in 10 infants with severe HIE. The early USG findings 
found in the study were cerebral edema in 9 and intraventricular hemorrhage in 2 of 
them.  In  all  10  of  them,  the  late  USG  finding  was  severe  cerebral  atrophy, 
predominantly in cortico-subcortical area. All of them were followed up for a period of 
3 years. Six out of the ten babies developed multiple disabilities. All of them developed 
microcephaly. It was concluded that USG was very useful in the diagnosis of hypoxic 
ischemic brain damage in term neonates as well as in predicting neurodevelopmental 
outcome.
STUDY JUSTIFICATION
In  developing  countries  like  India,  though  malnutrition  and  communicable 
diseases are still the major health hazards, there has been a welcome shift towards better 
care of neonates both in routine care and care of high risk neonates. Risk factors like 
birth  asphyxia,  jaundice,  sepsis  play  an  important  role  in  deciding  the  future 
development of the child.
       Approximately 500 babies with HIE are admitted every year in our newborn unit. 
The development of health infrastructure and effective tertiary level care has decreased 
the  mortality  rates,  thus  shifting  the  emphasis  to  morbidity  pattern.  Available  data 
regarding HIE in term babies and associated multiple risk factors are still confusing and 
conflicting. This issue is the focal point of this study.
           This study is expected to provide insight into the pathophysiology and the course 
of illness of HIE. Risk factors that have an impact on the outcome, when identified will 
help us to plan appropriate intervention. Early detection and intervention program to be 
planned for childhood disabilities can be based on the outcome of this study.
OBJECTIVES OF THE STUDY
1. To  assess the  neurodevelopmental  outcome  in  neonates  with  HIE  using  Munich 
Functional Developmental Scale.
2. To determine the association between staging of HIE (according to      Sarnat and 
Sarnat staging23) in the newborn period and      neurodevelopmental outcome at the 
age of one year. 
3. To identify the factors which have an impact on the neurodevelopmental outcome in 
neonates with HIE.
4. To compare the neurodevelopmental outcome assessed by Munich       Functional 
Developmental Scale with that assessed by Baroda       Developmental Screening 
Test (Abbreviated Bayley Scale of Infant       Development).
STUDY METHODOLOGY
Study design
This study was done as a Cohort study.
Setting
This  study  was  conducted  at  the  Institute  of  Child  Health  and  Hospital  for 
Children, Madras Medical College, a Tertiary care Children’s hospital in Chennai.
Study period
It was done during the period from November 2005 to April 2007.
Study Population
Neonates  with  Hypoxic  Ischemic  Encephalopathy  admitted  in  the  Medical 
Newborn Unit at the Institute of Child Health and Hospital for Children, Chennai were 
enrolled in the study.  
Inclusion Criteria
All term neonates with history suggestive of Perinatal  Asphyxia and clinically 
diagnosed to have HIE by Sarnat and Sarnat staging.
Exclusion Criteria
• Infants with sepsis (positive blood/CSF cultures).
• Neonates with birth weight <2.5 kgs.
• Severely dysmorphic infants with at least one major congenital    anomaly.
• Any congenital brain anomaly on Cranial Ultrasonogram. 
• Infants with hepatosplenomegaly and cataracts indicative of intrauterine infection.
• Presence  of  other  identifiable  causes  of  seizures  like  Hypoglycemia  and 
Hypocalcemia.
• Babies with suspected neuromuscular disorders.
Sample Size
Based  on  previous  studies,  the  incidence  of  neurodevelopmental  outcome  in 
neonates with HIE was expected to be about 40%. With 10% precision and alpha error 
of 5%, the required sample size was 92. 
Manoeuvre
        The study was conducted at the Medical Newborn Unit and Child Development 
Clinic  of  Institute  of  Child  Health  and Hospital  for  Children between the period of 
November 2005 and April 2007. The neonates were enrolled during the first six months 
of the study period and followed up for a period of one year.
           All neonates included in the study were staged by Sarnat and Sarnat staging23 
(except EEG) at admission and periodically every 12th hourly till day 3 of life. The age 
of the baby at admission and the sex was recorded in the proforma. The details regarding 
the presence of antenatal illnesses, place of delivery, mode of presentation, duration of 
second stage of labour and mode of delivery were obtained by interviewing the mothers 
and from the discharge notes of the referring hospital. As this study was conducted in an 
extramural newborn unit, reliable data regarding Apgar scores could not be obtained in 
most neonates. Every enrolled child was followed up during the hospital stay for the 
presence of seizures, onset of seizures if any, and the need for ventilatory support. The 
biochemical  parameters  of  the  neonates  were  analysed  for  detecting  conditions  like 
hypoglycemia  and hypocalcemia.  A Cranial  Ultrasonogram was performed on every 
child to look for features suggestive of HIE and to exclude any congenital anomaly of 
the brain. 
 At the time of discharge, the children were examined for the presence of abnormal 
neurological  signs.  The  weight,  length,  head  circumference  and  chest  circumference 
were noted for every child. The parents were counselled regarding the outcome of HIE 
and the need for follow up and periodic development assessment. A Child Development 
Clinic (CDC) card was issued to every child, with details of follow up dates.
 The infants were followed up at 1, 3, 6, 9, and 12 months of age. At each visit, the 
child’s weight,  length,  head circumference and chest  circumference were noted.  The 
child’s  development  was  assessed  by  Munich  Functional  Developmental  Scale  and 
Abbreviated Bayley Scales of Infant Development (Baroda Developmental Screening 
Chart).
              In Munich Functional Developmental Scale, the infants were assessed in seven 
functional  areas  namely  Crawling  age,  Sitting  age,  Walking  age,  Grasping  age, 
Perception age, Speech age and Social age. 
There are 13 items in each area. A particular area of development was completely 
clarified  only when the  child  had correctly  executed  at  least  3  items.  After  the  last 
positively rated item, three consecutive difficult  items were clarified which the child 
could not execute. The items performed by the child were plotted on the graph.
In BDST, the performance of the child was noted by plotting the total number of 
items passed by him/her (score) against the chronological age. The intersection of the 
horizontal level of this score with the 50% level curve indicated the developmental age 
of the child, i.e., the age at which 50% normal children are expected to have the same 
scale. The developmental quotient was calculated as follows:
Developmental age 
x  100
Chronological age   
If the child’s developmental quotient was 77.5 (-1.5 SD) or less, the child was 
considered to have delayed development13.
 Visual assessment was done at 3 months and 6 months by 
• Gross appearance of the eyes
• Perception and following of a bright object
• Visual fixation on coloured objects
• Red reflex by ophthalmoscopy
• Eye movements
• Fundoscopy
• Retinoscopy for refractive error
Auditory evaluation was done at 6 months and one year by Behaviour Observation 
Audiometry24. BERA could not be done as the facilities were not available in our 
hospital.
         At the end of one year, the correlation between the HIE stages and the final 
neurodevelopmental outcome was analysed. The results are as follows. 
RESULTS
The infants  were enrolled from November  2005 to  April  2006 and they were 
followed up for a period of one year from the date of enrollment. During the enrollment 
period, the total number of admissions in the newborn unit was 1800. Number of babies 
with HIE were 292, constituting 16.22% of total admissions. Among them, 103 babies 
died during the hospital stay contributing to 24.81% of total number of deaths in the 
newborn unit. Among the 189 who survived, 42 neonates were excluded after applying 
the exclusion criteria. The remaining 147 neonates were followed up. Their parents were 
counselled and CDC cards were issued at the time of discharge. 25 of them were lost to 
follow up. 2 infants died after discharge. At the end of the study period, 120 of them had 
completed the follow up. The data from those 120 newborns were analysed using SPSS 
for windows version 11.0.
The observations were analysed under the following headings:
        I. Baseline data
        II. Profile of HIE
        III. Analysis of neurodevelopmental outcome
        IV.  Analysis of the risk factors for outcome
I. Baseline data
           The demographic details of the study population were analysed in the following 
ways:
(i) Sex distribution among HIE neonates




Among the 120 babies with HIE who were followed up, 42.5% were males and 57.5% 
were females.
(ii) Antenatal illnesses among mother with HIE babies.
Table 4:  Antenatal illnesses among mother with HIE babies.




Antepartum Hemorrhage 6 5.0
Obstructed Labour 3 2.5
Infections 3 2.5
Nil 50 41.66
Among  the  mothers  with  HIE  babies,  41.66%  had  normal  antenatal  period; 
24.2% of them had anemia,20% of them had PIH, 4.16% had GDM, 5% had antepartum 
hemorrhage, 2.5% had obstructed labour and 2.5% had medical illnesses like infections 
(2 cases of UTI and 1 case of LRI), heart disease etc..
(iii)  Place of Delivery
Table 5: Place of Delivery




Corporation Hospital /District 
Hospital 37 30.83
Primary Health center / 
Subcentre 38 31.66
Private Nursing Home 32 26.66
Home / Transit 6 5.0
Among the 120 babies included in the study, 95% had institutional deliveries.
(iv) Mode of Presentation 
Table 6: Mode of Presentation
Mode of Presentation n %
    Vertex 113 94.16
    Breech 6 5
    Others 1 0.8
Among the babies included in the study, 94% had vertex presentation and 5% had 
breech presentation.
(v) Duration of Second Stage of Labour
          As the study was conducted in an extramural unit, history regarding duration of 
second stage of labour could not be obtained in many cases and thus could not be 
analysed. Among the 40 cases in whom the history could be obtained, 26 of them had 
prolonged second stage of labour. 
(vi) Apgar score
         As this study was conducted in an extramural newborn unit, reliable data regarding 
Apgar scores could not be obtained in most neonates.   
(vii) Mode of Delivery
Table 7: Mode of Delivery:
Mode of delivery n      %
    Normal Vaginal 78 65
    LSCS 37 30.83
 Vacuum / Forceps 5 4.16
65% of babies were delivered by normal vaginal delivery, 30.83% by caesarian section 
and 4.16% by forceps delivery
(viii) Age at Admission 
                                Table 8: Age at Admission 
Age at admission in 
Hrs)
N %





Among the babies included in the study, 56.6% of them were referred to the hospital 
within 12 hours.
II. Profile of HIE
(i) Stages of HIE
Table 9: Stages of HIE
   Stage of HIE n %
    HIE – I 30 25
    HIE – II 64 53.33
    HIE – III 26 21.66
Among the 120 babies, 25.0% belonged to HIE Stage I, 53.33% to HIE Stage II and 
21.66% to HIE Stage III.
(ii) Incidence of Seizures among HIE babies
   
                   Table 10: Incidence of Seizures among HIE babies
           HIE Incidence of Seizures p-value
Stage n %
       I (n=30) -    -
      II (n=64) 58 90.6
     III (n=26) 12 46.2
TOTAL (n=120) 70 58.33
0.00*
Overall, seizures occurred in 58.33% of babies with HIE. Seizures occurred in 
none of the HIE I babies, 90.6% of HIE Stage II and 46.2% of HIE Stage III. Incidence 
of seizures was highest in HIE II and it was statistically significant. 
(iii) Onset of Seizures
                           
                           Table 11: Onset of Seizures
Stage of
HIE
Onset of seizures in HIE
   <6 hrs 6 – 24 hrs > 24 hrs
n % n % n %
p-value
I (n=0) - - - - - -
II (n=58) 21 36.2 29 50.0 8 13.8
III (n=12) 8 66.7 4 33.3 - -
Total (n=70) 29 41.42 33 47.14 9 12.85
0.02*
Among HIE Stage II babies with seizures, 36.20% developed seizures within 6 
hrs of life, 50% at 6-24 hrs and 13.7% after 24 hrs of  life. Among HIE Stage III babies 
with  seizures,  66.66%  developed  seizures  within  6  hrs  of  life  and  33.33%  at 
6-24hrs.Onset of seizures was found to be earlier as the HIE stage increased and it was 
statistically significant.
(iv) Need for Ventilatory Support
                       Table 12: Need for Ventilatory Support:
HIE Stage
Need for ventilatory support
n %
p-value
I (n=30) - -
II (n=64) 6 9.37
III (n=26) 15 57.69
Total (n=120) 21 17.5
0.00*
None of the HIE I required ventilatory support. 9.37% of HIE II & 57.69% of HIE 
III needed ventilatory support .Need for ventilatory support significantly increased as the 
stage of HIE increased.
(v) Cranial Ultra Sonogram in HIE Babies
Table 13: Cranial Ultra Sonogram in HIE Babies
Stages
of HIE
Ultrasound findings in HIE
Normal       Abnormal  
n % n %
p-value
I (n=30) 20 100.0 - -
II (n=64) 51 79.7 13 20.3
    III (n=26) 11 42.3 15 57.7
Total (n=120) 92 76.7 28 23.3
0.00*
More than 50% of HIE III babies had abnormal USG and none of the HIE I babies 
had  abnormal  USG  .The  difference  was  statistically  significant.  Loss  of  sulci  gyri 
echodistinction, presence of ischemic changes, hemorrhages, PVL and edema (midline 
shift, ventricular compression) were the abnormal USG findings.
(vi) Duration of hospital stay
Table 14: Duration of hospital stay
Stages
of HIE
Duration of hospital stay
< 1 week < 1 week
n % n %
p-value
I (n=30) 28 93.3 2 6.7
II(n=64) 26 40.6 38 59.4
III (n=26) - - 26 100.0
Total 
(n=120)
54 45.0 66 55.0
0.00*
The hospital stay increased as the HIE stage increased and all babies with HIE III 
stayed  in  the  hospital  for  more  than  one  week.  The  difference  was  found  to  be 
statistically significant.
(vii) Neurological status at Discharge
                   Table 15: Neurological status at Discharge
Stages
of HIE
Neurological status at discharge
Normal       Abnormal  
n % n %
p-value
I (n=30) 30 100.0 - -
II (n=64) 44 68.8 20 31.3
    III 
(n=26)
- - 26 100.0
Total 
(n=120)
74 61.7 46 38.3
0.00*
All the HIE I babies were neurologically normal at discharge and all HIE III babies 
were  neurologically  abnormal  at  discharge.  One  third  of  the  HIE II  babies  were 
abnormal at discharge.
III. Analysis of Neurodevelopmental Outcome 
A. Assessment by Munich Functional Developmental Scale             
(i) Neurodevelopmental Outcome in HIE by Munich Functional Developmental 
Diagnostic Scale 
Table 16: 
Neurodevelopmental Outcome in HIE by Munich Functional Developmental 
Diagnostic Scale
HIE Stage




I (n=30) 2 6.66
II (n=64) 29 45.31
III (n=26) 26 100
Total (n=120) 57 47.5
0.00*
According to Munich Functional Developmental Diagnostic scale, 47.5% of babies 
with HIE had adverse neurodevelopmental outcome at 1 year of age. 6.6% of HIE 
Stage I babies, 45.31% of HIE Stage II babies and all HIE Stage III babies had 
developmental delay at 1 year of age.
(ii) Profile of delay in specific developmental areas – assessment by Munich 
Functional Developmental Diagnostic Scale.
Table 17:
 Profile of delay in specific developmental areas – assessment by Munich 





HIE I (n=2) HIE II (n=29) HIE (n=26)
n % n % n %
Crawling 
Age
- - 19 65.51 21 80.76
Sitting 
Age
- - 20 68.96 20 80.76
Walking 
Age
1 50 19 65.51 22 84.61
Grasping 
Age
2 100 23 79.31 24 92.30
Perceptio
n Age
- - 18 62.06 19 73.07
Speech 
Age
1 50 20 68.96 24 92.30
Social 
Age
- - 18 62.06 20 76.92
        When the developmental domains were assessed, it was found that no specific area 
was more commonly affected than the rest. However for a given child, the delay was not 
necessarily global.
(iii) Predictability of neurodevelopmental  outcome at 1 year by Munich Functional 
Developmental assessment at 3 months.
Table 18:
 Predictability of neurodevelopmental outcome at 1 year by Munich   Functional 
Developmental assessment at 3 months.
 
                 
Neurodevelopmen
tal Outcome at 3 
months
Neurodevelopmental outcome at 1 year
Abnormal Normal
Abnormal (n=59) 56 3
Normal (n=61) 1 60
Total 57 63
    
    Kappa statistic- 0.93 (p-value 0.00)
Sensitivity  of  3rd month  assessment  in  predicting  development  at  1  year  was 
98.24%, specificity  was 95.23%, positive predictive value was 94.91% and negative 
predictive value was 98.36%.
B. Assessment by Baroda Developmental Screening Test.
(i) Incidence of developmental delay in HIE- Assessed by Baroda Developmental 
Screening Test.
Table 19: 











According to Baroda Development Screening Test,  44.16% of HIE babies had 
adverse neurodevelopmental outcome at 1 year of age. 6.6% of HIE I babies, 40.62% of 
HIE II Babies and 96.15% of HIE III babies had delayed development at 1 year of age.
(ii) Developmental  Quotient  in  HIE  Babies  –  Assessed  by  Baroda  Development 
Screening Test.
a. Among all babies
Table 20: 
Developmental Quotient in HIE Babies







 b. Among babies with developmental delay
Table 21: 










The mean developmental quotient among HIE I was 94, HIE II was 75, and HIE 
III was 36.The mean developmental quotient among those with developmental delay 
was as follows- 69 in HIE I, 53 in HIE II and 36 in HIE III. The difference in the mean 
DQ among the different stages of HIE was statistically significant. 
C. Comparison of Munich Functional Developmental Diagnostic scale (MFDS) 
and Baroda Developmental Screening Test (BDST).
Table 22: 
Comparison of Munich Functional Developmental
Diagnostic scale (MFDS) and Baroda  Developmental Screening Test
Developmental delay 
by MFDS
Developmental delay by 
BDST
  Yes No
Total
Yes 53 4 57
No 0 63 63
Total 53 67
Kappa statistic 0.93 (p-value 0.00)
MFDS had a sensitivity of 100%, specificity of 94.02%, positive predictive value 
of 92.98% and negative predictive value of 100% in predicting the developmental delay 
among HIE babies as assessed by BDST.
D. Co-Morbidity among Babies with Developmental Delay.
(i) Visual Disturbance:
Table 23: 





I (n=2) - -
II (n=29) 1 3.44
III (n=26) 5 19.23
Total (n=57) 6 10.52
10.52 % of those with developmental delay had cortical blindness which 
amounted to 5% of total HIE babies .Other ophthalmic problems like strabismus & 
nystagmus were found in 9 babies, 15.78% of those with developmental delay.
(ii) Hearing Impairment:
Table 24: 







      III   (n=26) 6 23.07
Total(n=57) 7 12.28
12.28% of those with developmental delay (5.87% of all HIE babies) had hearing 
impairment. The incidence of hearing impairment was not significantly higher in HIE 
III. 
(iii)Presence of Seizures at 1 year of age among those with  developmental delay.
(iv)
Table 25: 
Presence of Seizures at 1 year of age among those with
developmental delay.
HIE Stage
Prevalence of Seizures p-value
n % 0.02
I (n=2) - -
II (n=29) 4 13.79
III (n=26) 12 46.15
Total (n=57) 16 28.07
28.07% of those with adverse neurodevelopmental  outcome continued to have 
seizures at 1 year of age (46.15% among HIE III and 13.79% among HIE II, None of 
HIE I had seizures at 1 year).Persistence of seizures at 1 year was significantly high in 
HIE III. 
(iv)  Microcephaly among those with developmental delay
Table 26: Microcephaly among those with developmental delay
HIE Stage








None of the HIE babies studied were microcephalic at birth. Among babies with 
adverse outcome, 10.3% of HIE II and 46.15% of HIE III babies had microcephaly at 1 
year. None of the HIE I babies developed microcephaly. 
73.68%  of  those  with  developmental  delay  did  not  have  microcephaly. 
Microcephaly was significantly higher in HIE III.
              IV. Analysis of the risk factors for outcome
(i) Predictors of neurodevelopmental outcome among HIE babies 
Table 27: Predictors of neurodevelopmental outcome among HIE babies












































































































































Age at admission 
square test
        
The sex of the neonate, antenatal illnesses, place of delivery, mode of delivery, 
mode  of  presentation  and  age  at  admission  did  not  have  statistically  significant 
association  with  neurodevelopmental  outcome.  The  following  had  statistically 
significant  association  with  neurodevelopmental  outcome-  HIE  stage,  presence  of 
seizures,  need  for  ventilatory  support,  abnormal  cranial  ultrasonogram,  abnormal 
neurological status at discharge and a hospital stay of more than one week.
(ii) Onset of seizures as a predictor of neurodevelopmental outcome among 
those with seizures
Table 28: 




       Yes         No
n % n %
p-value
< 6 hrs  23  79.3  6  20.7
6-24 hrs  15  45.5  18  54.5
> 24 hrs  4  44.4  5  55.6
0.02
          Earlier onset of seizures was significantly associated with adverse 
neurodevelopmental outcome.  
(iii)  Univariate  Logistic  Regression –  Risk  Factors  for  Neurodevelopmental 
Outcome
Table 29: Univariate Logistic Regression – Risk Factors for Neurodevelopmental 
Outcome
Risk Factors O.R. 95% C.I. p-value
Presence of seizures 3.3 1.5,      7.1 0.002
Need for Ventilatory support   33.4 4.3,  259.1 0.001
Abnormal Cranial Ultrasound 25.6 5.7,  114.8 0.00
Hospital stay ≥ 1 week 13.3 5.4,    32.7 0.00
Abnormal Neurological Status at discharge   22.3  8.1,    61.7 0.00
As all neonates with HIE stage III had developmental delay, an Odds ratio could 
not be calculated for the same. Presence of seizures in the early neonatal period was 
significantly associated with adverse neurodevelopmental outcome with an Odds ratio of 
3.3. Developmental delay was more common in those who needed ventilatory support. 
This was statistically significant with an Odds ratio of 33.4.  A child with an abnormal 
cranial ultrasound was 25 times at higher risk of developing delayed milestones when 
compared to those with normal ultrasonogram. Similarly those who were neurologically 
abnormal at discharge were more likely to have developmental delay (Odds ratio 22.3). 
Hospital  stay of  ≥ 1 week had a statistically significant  association with an adverse 
neurodevelopmental  outcome  with  an  Odds  ratio  of  13.3.  The  same  variables  were 
subjected to Multivariate Logistic Regression
(iv) Multiple Logistic Regression- Risk Factors for Neurodevelopmental Outcome
Table 30: Multiple Logistic Regression- Risk Factors for Neurodevelopmental 
Outcome
Risk Factors O.R. 95% C.I. p-value
Presence of seizures 3.2 1.0 , 10.1 0.04
Need for Ventilatory support          5.7 0.5 , 59.7      0.15
Abnormal Cranial Ultrasound        11.1 2.2 , 56.5 0.004
Abnormal Neurological Status at discharge 8.7 2.6 , 29.8 0.001
Hospital stay ≥ 1 week 1.2 0.3,   4.9 0.78
When the same variables were subjected to multivariate analysis, it was found that 
the need for ventilatory support and a hospital stay of more than one week were not 
predictive of developmental delay in HIE.
Presence of seizures, an abnormal cranial ultrasonogram and abnormal neurological 
signs at the time of discharge had a statistically significant association with delayed 
neurodevelopment with a p value of <0.05.
SUMMARY
        Analysis of the results showed that seizures were more common in HIE II when 
compared to HIE III. The possibility of detecting an abnormal finding in the cranial 
ultrasound  increased  as  the  HIE  stage  increased.  Similarly  abnormal  neurological 
findings at the time of discharge were more common in HIE III when compared to other 
stages.  
       The incidence of developmental delay correlated with the HIE stages. The incidence 
increased with increase in the stage. There was no predilection for involvement of any 
specific  area  when  assessed  by  Munich  Functional  Developmental  Scale.  The 
developmental  delay  detected  at  3rd  month  of  life  was  a  sensitive  predictor  of 
neurodevelopmental  delay  at  1  year.  The  results  obtained  by  Munich  Functional 
Developmental Scale agreed with those of Baroda Developmental Screening Test. 
       Analysis of risk factors for an adverse neurodevelopmental outcome showed that the 
maternal  or  perinatal  factors  were  not  predictive  of  the  long  term  outcome.  The 
predictors  of  delayed  development  were  HIE  stage,  occurrence  of  seizures  in  the 
neonatal period, earlier onset of seizures, abnormal neurological status at discharge and 
abnormal cranial ultrasonogram.
DISCUSSION
The  incidence  of  birth  asphyxia  is  reported  to  be  much  higher  in  developing 
countries, and presents a formidable challenge to health professionals from the point of 
view of preventive as well as therapeutic interventions.   In our study, HIE constituted 
16.22% of  the  total  newborn  admissions  which  correlated  exactly  with  the  national 
statistics  (16.0%)  as  reported  in  National  Neonatal  Perinatal  Database  (NNPD) 
2002-200325.  HIE contributed to 24.8% of total neonatal deaths in our newborn unit, 
which was slightly higher than the national reports25 (19.0%). In a study done by Jaimin 
et al16, HIE accounted for 22.25% of total NICU deaths which was similar to our study.
            Longitudinal studies are time consuming and have high fall out rate, as shown in 
the study by Bhargava et al26 from Delhi, where, of the 572 Low Birth Weight babies 
with birth weight <2000 grams, only 1/3 of the sample was available at 6 yrs. In another 
study27 from Goa on early intervention of LBW, it was noted that, only half of the babies 
could be followed up till 1 year of age. In our study, we were able to follow up 80 % of 
the babies till one year of age.
             Occurrence of seizures was more common in HIE II than in HIE III which 
correlated with the results of Sarnat and Sarnat23.  It is important to closely follow the 
neurodevelopment  of  neonates  with  HIE  as  they  carry  a  high  risk  of  developing 
neurological abnormalities. The incidence of developmental delay in HIE was 47.5% in 
the present study. It was comparable with the studies done by Samatha et al13 (49.45%), 
Rajadurai et  al28 (42.85%), Hallioglu O et al17 (42.55%) and Thomson et al29 (42%). 
Jaimin et al16 reported a higher incidence of 69.44% but their study had included only 
HIE II and HIE III, excluding HIE I babies who are expected to have better outcomes. 
Our  observations  also  confirm  with  Sarnat  and  Sarnat23 in  that,  there  is  a 
demonstrable relationship between severity of HIE and neurodevelopmental outcome. 
The incidence of developmental delay was 6.6% in HIE I and 40.62% in HIE II in the 
present study. It was similar to the observations of Samatha et al13 (5.4% and 37.8% in 
HIE I  and HIE II  respectively).  All  the  HIE III  babies  in  our  study  had a  delayed 
development which correlated with the observations of Sarnat and Sarnat23. According 
to their study, one half of HIE III babies don’t survive and the other half are left with 
neurological sequelae. However Samatha et al13 reported only 77% incidence of delay in 
HIE III. Early diagnosis in these infants is imperative as the handicap can be reduced to 
a great extent by early intervention.
In  the  present  study,  the  developmental  assessment  was  done  by  Munich 
Functional Developmental Diagnostic Scale. To the best of our knowledge, there are no 
articles  published  in  English  literature  regarding  the  early  diagnosis  by  Munich 
Functional Developmental Diagnostic Scale and therefore we were unable to compare 
our  results  with  similar  studies.   In  this  study,  it  was  found  that  no  specific 
developmental  area  was  more  commonly  affected  than  the  rest  when analysed  as  a 
whole. But when analysed on an individual child basis, most children had delay in few 
specific areas and only few infants with severe delay were affected globally. The early 
intervention programs can be directed towards those specific functional areas in which 
there is a delay. This therapeutic approach is the prime feature of  Munich Functional 
Diagnostic Scale.
This  study  has  also  assessed  the  predictive  value  of  Munich  developmental 
assessment  at  3  months  of  age  as  a  screening  test  to  predict  neurodevelopmental 
outcome  in  babies  with  HIE  at  one  year  of  age.  The  3rd month  assessment  had  a 
sensitivity of  98.24%, specificity of 95.23%, positive predictive value of 94.91% and 
negative predictive value of  98.36%. Thus Munich  Functional  Diagnostic  Scale  is  a 
sensitive screening tool as early as 3 months of age. .  Based on this early diagnosis the 
child can be referred for early intervention in order to prevent a lifelong handicap. These 
results are similar to the observations of Samatha et al13 who had employed the Vojta's 
system of kinesiological diagnosis.  In their study, the sensitivity, specificity, positive 
and  negative  predictive  values  were  100% when  >3  abnormal  Vojta  reactions  of  3 
months were used to detect neuro-developmental outcome at one year of age. However 
Chaudhari et al30 reported only 26.6% prediction using abnormal Amiel Tison test at 3 
months of age. The differences are due to the varying sensitivities of the different scales 
used in the studies.
In our study, we had compared the results of Munich Functional Developmental 
Scale with those of Baroda Developmental  Screening Test  which is standardised for 
Indian  children. MFDS  had  a  sensitivity  of  100%,  specificity  of  94.02%,  positive 
predictive value of  92.98% and negative predictive value of  100% in predicting the 
developmental  delay  among  HIE  babies  as  assessed  by  BDST.  MFDS agreed  with 
BDST with a Kappa statistic of 0.93. Thus MFDS was found to be valid for Indian 
children. However it needs more extensive studies to confirm it. There are no previous 
studies comparing these two scales. Thus we couldn’t compare our results with similar 
studies.
In our study, the mean developmental quotient (DQ) was lower as the HIE stage 
increased.  The  difference  in  the  mean  DQ  among  the  HIE  stages  was  statistically 
significant. Similar observation was made in a study by Robertson et al19,  where the 
mean DQ correlated significantly with the HIE stage. 
Hearing impairment was found in 7 cases (5.87% of all HIE babies) in our study. 
As BERA could not be done, it was difficult to test  the objectivity, but the findings 
correlated with other studies31 in which the incidence of permanent hearing loss of 4% 
was observed at 3 months of age with BERA. Cortical blindness was found in 5% of 
HIE babies. Incidence of cortical blindness in HIE is not reported in any other study. 
Jaimin et al16 had reported 22% incidence of ophthalmic problems like strabismus and 
nystagmus. It was 15.78% in our study. Microcephaly occurred in 12.5% of our study 
population (26.32% of those with developmental delay).  Microcephaly was present in 
48% of the infants with HIE, compared with 3% of the controls in a study done by 
Eugenio Mercuria32 and his colleagues. The significantly different results between the 
two  studies  were  probably  because  of  the  different  standards  used  for  defining 
microcephaly. WHO standards for head circumference was used in the present study 
while charts33 designed by the Child Growth Foundation 1996 was used in their study.
In the present study, on analysing the risk factors for delayed development, it was 
found  that  the  maternal  or  perinatal  factors  did  not  predict  the  outcome.  This  was 
supported by Robertson C et al19 in their study. The stage of HIE correlated well with the 
outcome in our study as stated by Sarnat and Sarnat23. The same was observed in studies 
by Robertson C et al18, Rajadurai et al28 and Finer NN et al20.
Presence of seizures in the early neonatal period was a predictor of outcome in the 
present study which was supported by Finer NN et al20.  Our study states that earlier 
onset of seizures predicted an adverse neurodevelopment.
Mejaski-Bosnjak  et  al22 correlated  USG  and  neurodevelopmental  handicap  in 
infants with HIE. All of them were followed up for a period of 3 years. It was concluded 
that USG was very useful in the diagnosis of hypoxic ischemic brain damage in term 
neonates as  well  as  in  predicting neurodevelopmental  outcome.  Hallioglu et  al17 too 
concluded  that  abnormal  cranial  ultrasound  had  a  high  accuracy  in  predicting  the 
developmental outcome in HIE. In our study too, abnormal ultrasound predicted adverse 
neurodevelopment in HIE with an odds ratio of 11.1.
According to this present study, if an infant has abnormal neurological signs at the 
time of  discharge,  he/she has  a significantly  higher  risk of  manifesting neurological 
deficits during follow up at one year (Odds ratio 8.7). A similar study by Jaimin et al16 
demonstrated that   abnormal Examination at Day 7 has significant association with 
abnormal neurological status at the end of 1 year as assessed by Amiel Tison Method (P 
< 0.01, Positive predictive value of 91%). Supporting the same, Robertson et al19 had 
stated that the neurological examination at discharge from the Neonatal Intensive Care 
Unit was more useful than the presence of neonatal convulsions in identifying children 
with subsequent developmental delay. The need for ventilation and duration of hospital 
stay did not predict the outcome in our study as analysed by multiple logistic regression. 
Finer NN et al20 also had shown that there was no association between the need for early 
ventilation and subsequent outcome.
CONCLUSION
 About one half of the neonates with HIE have delayed development at one year of 
age as assessed by Munich Functional Developmental Scale.
 The  neurodevelopmental  outcome  worsens  as  the  severity  of  encephalopathy 
increases.
 Severe degrees of encephalopathy, presence of seizures, abnormal ultrasonogram 
and  abnormal  neurological  signs  at  the  time  of  discharge  predict  adverse 
neurodevelopmental outcome. 
 Munich Functional Developmental Scale is comparable to Baroda Developmental 
Screening Test in the developmental assessment of Indian children.
 The third month developmental assessment by Munich Functional Developmental 
Scale is predictive of the neurodevelopment at one year and can be employed 
as an effective screening tool.
Neonatal care is incomplete without adequate follow up, which is mandatory 
for early prediction of outcome and selection of infants who would benefit from 
early  interventions.  Successful  early  identification  of  delayed  development 
requires that the pediatricians be skilled in the use of screening tests and be 
aware of the strengths as well as the limitations of developmental screening. 
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ANNEXURE – I 
SARNAT AND SARNAT’S CLINICAL STAGES OF HIE






Muscle tone Normal Mild hypotonia Flaccid





Stretch reflexes Overactive Overactive Decreased or absent
Segmental myoclonus Present Present Absent
Complex Reflexes
Suck Weak Weak or absent Absent





Oculovestibular Normal Overactive Weak or absent
Tonic neck Slight Strong Absent











Heart Rate Tachycardia Bradycardia Variable
Bronchial and 































Duration <24 hours 2-14 days Hours to weeks
ANNEXURE – II
DATA COLLECTION FORM















Presentation : Vertex / Breech / Others
NATAL HISTORY
Place of Delivery : Med.  College  hospital  /  GH  /  Dist. 
Hospital / PHC / SC/ Private MC / NH/ 
Home / Others
Mode of Delivery : Normal  Vaginal  /  LSCS  /  Vacuum  / 
Forceps
Birth Weight :
Apgar (If Available) :
Resuscitation : Initial  Steps  /  Tactile  Stimulation,  O2 
Suction / BMV /  Intubation / Drugs /  Not 
Known
HIE STAGE:         I II III
No. of Seizure Episodes :
Onset of Seizures :
Co-Morbidity :
Investigations: Biochemical parameters;
                      
                         Cranial Ultrasonogram:
Treatment in NICU :
No of Days of Hospital Stay:
Condition at Discharge: Neurologically Normal / Abnormal







                             (During Follow Up)
History :
Persistence of Seizures after discharge : Yes / No
ANTHROPOMETRY







                                 Baroda Developmental Screening Test
BDST 1 Month 3 Months 6 Months 9 Months 12 Months
Score
Developmental Quotient at 1 year - 




























End of 12th 
Month
Safe Crawling
End of 11th 
Month
Cross-Coordinated crawling with hands and knees
End of 10th 
Month
(a) Swinging on hand and knees.
(b) Uncoordinated crawling.
(c) Able to come to sit with flexion of hip and 
rotation of trunk.
End of 9th 
Month
Commando Crawling
End of 8th 
Month
Transition Stage
End of 7th 
Month
(a) One arm lifted from the ground for 3 seconds.
(b) Parachute reaction.  
End of 6th 
Month
(a) Support with extended arm on half or full opened hands.
(b) When foundation is lifted from one side arms and legs 
of the higher side will be abducted (balance reaction).
End of 5th Interrupted elbow support by lifting the arm in co-
Month ordination with repeated extension of lifted legs 
(swimming).
End of 4th 
Month
Using safe elbow support
End of 3rd 
Month
(a) Raising head between 45 and 90º
(b) raising head for one minute minimum
(c) Beginning of elbow support
(d) Hips mostly in loose extension
End of 2nd 
Month
(a) Raising head 45º minimum
(b) Raising head 10 seconds minimum
End of 1st 
Month
Raising head for 3 Seconds minimum
Newborn
(a) Turns head from middle position to one side.
(b) Upper and Lower limbs in total flexion
(c) Reflex Creeping
SITTING AGE
End of 11th and 
12th Month
Safe balance in long-sit Position
End of 10th 
Month
(a) Coming to, sit from supine position only using furniture 
as support.
(b) Long-sit- free sitting with extended back and loosely 
extended legs.
End of 9th 
Month
Able to sit without support atleast one minute.
End of 8th 
Month
(a) Begins to pull up actively from the supine position if you 
offer finger as support.
(b) Sitting atleast five seconds independent with hand 
forward support.
End of 7th 
Month
(a) Turning over from supine to prone position actively.
(b) Playing with the feet in supine position (hand feet co-
ordination).
End of 6th 
Month
(a) During traction-reaction both arms in beginning of 
flexion.
((b) In sitting position the head is well controlled, if trunk is 
inclined to all 
four directions.
End of 5th 
Month
(a) During traction-reaction head is lifted in lengthening of 
spine.
(b) Head in straight position even if trunk is inclined aside 
passively.
End of 4th 
Month
During traction-reaction head and loosely flexed legs are 
rising.
End of 3rd 
Month
(a) In sitting position head is held straight for about half a 
minute.
(b) In horizontal floating position head is not falling 
backwards.
End of 2nd 
month
In sitting position head is in straight position at least five 
seconds.
End of 1st 
Month
In supine position head is kept in middle position at least 
five seconds.
Newborn
(a) Head kept aside without preferring one side.
(b) Struggling without preferring one side.
(c) Head lifted from forward in sitting position several times 
for one second.
PERCEPTION AGE
End of 12th Month (a) Pulling a rope to get a desired toy (toy with rope).
(b) Let fall coins into the small box.
End of 11th and 10th 
Month
(a) is throwing away toys with intention.
(b) Touching details with the fore finger (touching the 
eyes, nose etc. of the doll).
End of the 9th Month Recognizing cubes inside a box and grasping it.
End of 8th and 7th 
Month
Tries to reach a toy which only can be got by changing the 
position.
End of 6th Month Is following a fallen down toy with it’s eyes.
End of 5th Month Is looking towards resulted noise
End of 4th Month Watching a toy in his hand.
End of 3rd and 2nd 
Month
(a) is following a  red rattle from one corner of the eye to 
the other.
(b) is watching a ringing bell by stopping its movements 
and fixing the eyes for a short moment.
End of 1st Month Is following a red rattle with the eyes to the both sides 
about 45º
Newborn Reacting unwilling to extreme light and noise effect.
GRASPING AGE
End of 12th and 11th 
Month
Grasping small things with flexed fore finger and opponent 
thumb (forceps-grip).
End of 10th Month (a) Grasping small things with extended fore finger and 
opponent thumb. (Pincer- grip).
End of 9th Month Lets thing fall down with intention.
End of 8th and 7th 
Month
(a) Grasping with both hands ever one cube and is holding 
them a short moment.
(b) Take a coin between two fingers and extended thumb 
without touching the palmar hand.
End of 6th Month (a)Is Grasping offered toys directly.
(b) Palmar grasping: with the whole palmar side of hand 
and extended thumb.
End of  5th Month Brings hands to the toy and touching it
End of 4th Month (a) Hands mostly half opened
(b) hand-hand co-ordination (hands playing together)
(c) Put toys into the mouth (hand-mouth-coordination).
End of 3rd Month Moves half opened hands in direction of an offered red 
toy.
End of 2nd Month Transition stage:-hands mostly light opened.
Newborn (a) Hands mostly fisted
(b) Strong hand grasping reflexes.
WALKING AGE
End of 12th Month (a) Side-step waling along furniture.
(b) Steps forward, hold on one hand.
End of 11th Month (a) Pulls up to stand using furniture as support.
(b) Making steps on one place and aside.
(c) Stepping forward with support on both hands.
End of 10th Month Standing with holding on furniture.
End of 9th Month Standing with support and holding the own weight for half 
a minute.
End of 8th Month Transition stage
End of 7th Month Bouncing with support
End of 6th Month (a) Extension in knees and hip so that the baby can hold its 
weight atleast 2 seconds.
(b) In between touching floor with the whole sole of feet.
End of 5th month Tip-Toe position
End of 4th Month When touching the floor repeated interruption of flexion of 
legs by light extension of knee and ankle joint.
End of 3rd Month Touching ground with flexed legs.
End of 2nd Month Transition stage: Legs – support reaction and walking –
automatism slowly wears off.
End of 1st Month Like newborn.
Newborn (a) Primitive leg support reaction: Extension of hip and 
knees when placed on the floor.
(b) Walking automatically when weight is shifted from one 
leg to another.
SPEECH AGE
End of 12th Month First Meaningful syllables.
End of 11th Month Imitate sounds (produced by lip vibrations)
End of 10th Month Dialogue correctly imitate familiar syllables 
End of 9th Month Distinct double syllables
End of 8th Month Whispering
End of 7th Month & 6th 
Month
Babbles continuously and pronounces clearly difference syllables 
with varying volumes and pitch
End of 5th Month Rhythmic coins of syllables
End of 4th Month Fricative sounds (w,f)
Labial sounds (m,b)
End of 3rd Month r-r-r- chains
End of 2nd Month Guttural sounds e-eche, eh-che, e-rrhe
End of 1st Month Vowel: sounds between ‘a’, ‘an’, ‘ae’, often connected with ‘h’.
New born
(a) cries if not in the mood
(b) strange sucking reflex
SOCIAL AGE
End of 12th Month When requested, in words or with gestures, gives one object to 
familiar person
End of 11th Month Can refuse a request by protesting 
End of 10th and 9th Month Will resist an attempt however, careful to take away a toy.
End of 8th Month React happily to hide – and seek – games.
End of 7th Month Observes intensely the activities of the familiar person.
End of 6th Month Behave differently with familiar and unfamiliar persons.
End of 5th Month and 4th Month Laughs loudly when it is teased
End of 3rd Month Social smile (2nd month)
End of 2nd Month Stares at the face and follows its movements.
End of 1st Month Stops its movement for a second on seeing a face
New born Is pacified, when baby carried around
ANNEXURE – IV
BARODA DEVELOPMENTAL SCREENING 
TEST
BARODA DEVELOPMENTAL SCREENING TEST
Screening Test items with Serial Numbering and Age Grouping: The Corresponding Number on 




S.No.         Items BSID No. Age Placements (mon)
    50%                    90%
1 1. Arms and legs thrust in play.
2. Momentary regard.











2. 4. Responds to sound.
5. Follows moving person











3. 7. Social smile/vocalises
8. Eye co-ordination










4. 10. Holds head steady
11. Recognises mother










5. 13. Play with rattle / hand play
14. Reaches for dangling ring










6. 16. Turns head to sound
17. Turns from back to side










7. 19. Discriminates strangers 







8. 21. Bangs in play







9. 23. Retains two things in two 
hands
24.Pulls to stand
25. Playful response to mirror 
image













10. 27. Pulls string – secures toy











11. 30. Rings bells purposefully
31. Fine prehension
32. Raises to sit





















13 to 15 36. Inhibits on command
37. Midline skills










































19 to 24 47. Shows shoes, etc
48. Two words
49. Walks up and down stairs 
with help













25 to 30 51. Two word sentences
52. Names three objects
53. Stands on one foot
54. Walks up and down stairs 
without help
134
144
*60,61
*57, 58
21.2
24.1
26.6
24.4
28.8
29.0
29.0
29.6
